These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9876777)

  • 1. The presence of atopy does not determine the type of cellular infiltrate in nasal polyps.
    Park HS; Kim HY; Nahm DH; Park K; Suh KS; Yim H
    Allergy Asthma Proc; 1998; 19(6):373-7. PubMed ID: 9876777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical characterization of cellular infiltrate in nasal polyp from aspirin-sensitive asthmatic patients.
    Park HS; Nahm DH; Park K; Suh KS; Yim HE
    Ann Allergy Asthma Immunol; 1998 Sep; 81(3):219-24. PubMed ID: 9759797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of mast cells and eosinophils in nasal polyps from atopic and nonatopic subjects: a morphometric study.
    Pawliczak R; Kowalski ML; Danilewicz M; Wagrowska-Danilewicz M; Lewandowski A
    Am J Rhinol; 1997; 11(4):257-62. PubMed ID: 9292175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of activated eosinophils in nasal polyps of an aspirin-induced asthma patient.
    Ogata Y; Okinaka Y; Takahashi M
    Rhinology; 1999 Mar; 37(1):16-20. PubMed ID: 10229976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathogenesis of nasal polyposis by immunoglobulin E and interleukin-5 is completed by transforming growth factor-beta1.
    Hirschberg A; Jókúti A; Darvas Z; Almay K; Répássy G; Falus A
    Laryngoscope; 2003 Jan; 113(1):120-4. PubMed ID: 12514394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunohistological study of eosinophilic infiltration of nasal polyps in aspirin-induced asthma].
    Yoshimi R; Takamura H; Takasaki K; Tsurumoto H; Kumagami H
    Nihon Jibiinkoka Gakkai Kaiho; 1993 Nov; 96(11):1922-5. PubMed ID: 8283343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Airway inflammation in nasal polyposis: immunopathological aspects of relation to asthma.
    Ediger D; Sin BA; Heper A; Anadolu Y; Misirligil Z
    Clin Exp Allergy; 2005 Mar; 35(3):319-26. PubMed ID: 15784110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of inflammatory mediators of mast cells and eosinophils in native nasal lavage fluid in nasal polyposis.
    Di Lorenzo G; Drago A; Esposito Pellitteri M; Candore G; Colombo A; Gervasi F; Pacor ML; Purello D'Ambrosio F; Caruso C
    Int Arch Allergy Immunol; 2001 Jun; 125(2):164-75. PubMed ID: 11435734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of eosinophil granule proteins in nasal mucosa of atopic patients with nasal polyposis.
    Min YG; Kim YJ; Yun YS
    ORL J Otorhinolaryngol Relat Spec; 1996; 58(2):82-6. PubMed ID: 8736052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis.
    Shin HW; Kim DK; Park MH; Eun KM; Lee M; So D; Kong IG; Mo JH; Yang MS; Jin HR; Park JW; Kim DW
    J Allergy Clin Immunol; 2015 Jun; 135(6):1476-85.e7. PubMed ID: 25725991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of mast and goblet cells in the pathogenesis of nasal polyps.
    Kitapçi F; Muluk NB; Atasoy P; Koç C
    J Otolaryngol; 2006 Apr; 35(2):122-32. PubMed ID: 16527032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mast cells in eosinophilic and neutrophilic nasal polyps. Cytological and histological examinations].
    Miszke A; Sanokowska E; Lis G
    Otolaryngol Pol; 1998; 52(3):321-6. PubMed ID: 9760776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory mediators and eosinophilia in atopic and non-atopic patients with nasal polyposis.
    Scavuzzo MC; Fattori B; Ruffoli R; Rocchi V; Carpi A; Berni R; Giambelluca MA; Giannessi F
    Biomed Pharmacother; 2005 Jul; 59(6):323-9. PubMed ID: 15935609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic rhinosinusitis--need for further classification?
    Rudack C; Sachse F; Alberty J
    Inflamm Res; 2004 Mar; 53(3):111-7. PubMed ID: 15021966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgE production from the nasal polyp tissue: comparison between atopic and non-atopic subjects.
    Kim HY; Nahm DH; Suh KS; Park HS
    Korean J Intern Med; 1998 Jul; 13(2):83-7. PubMed ID: 9735661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of ecalectin, a novel eosinophil chemoattractant, in nasal polyps.
    Iino Y; Miyazawa T; Kakizaki K; Saigusa H; Katano H; Shiga J; Kanegasaki S
    Acta Otolaryngol; 2006 Jan; 126(1):43-50. PubMed ID: 16308254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nasal polyp inflammation. Effect of topical nasal steroid.
    Kanai N; Denburg J; Jordana M; Dolovich J
    Am J Respir Crit Care Med; 1994 Oct; 150(4):1094-100. PubMed ID: 7921442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eosinophil infiltration and activation in nasal polyposis.
    Fan GK; Wang H; Takenaka H
    Acta Otolaryngol; 2007 May; 127(5):521-6. PubMed ID: 17453479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eosinophils and neutrophils in biopsies from the middle ear of atopic children with otitis media with effusion.
    Amin K; Hurst DS; Roomans GM; Venge P; Sevéus L
    Inflamm Res; 1999 Dec; 48(12):626-31. PubMed ID: 10669113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of prostaglandin D2 synthase in activated eosinophils in nasal polyps.
    Hyo S; Kawata R; Kadoyama K; Eguchi N; Kubota T; Takenaka H; Urade Y
    Arch Otolaryngol Head Neck Surg; 2007 Jul; 133(7):693-700. PubMed ID: 17638783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.